Read + Share
Alahyari S, Rajaeinejad M, Jalaeikhoo H, Chegini L, et al. Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+
and CD16+ cells may predict severity and prognosis. PLoS One 2022;17:e0268712.
PMID: 35930526
|
 |
|
Alahyari S, Rajaeinejad M, Jalaeikhoo H, Chegini L, et al. Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+
and CD16+ cells may predict severity and prognosis. PLoS One 2022;17:e0268712.
PMID: 35930526
|
|
|
|